| Literature DB >> 32511780 |
Nabarun Chakraborty1,2, David L Waning3, Aarti Gautam2, Allison Hoke2,4, Bintu Sowe2,4, Dana Youssef2,4, Stephan Butler1,2, Michael Savaglio5, Paul J Childress5, Raina Kumar2, Candace Moyler2,4, George Dimitrov1,2, Melissa A Kacena5,6, Rasha Hammamieh2.
Abstract
Prolonged residence of mice in spaceflight is a scientifically robust and ethically ratified model of muscle atrophy caused by continued unloading. Under the Rodent Research Program of the National Aeronautics and Space Administration (NASA), we assayed the large-scale mRNA and metabolomic perturbations in the quadriceps of C57BL/6j male mice that lived in spaceflight (FLT) or on the ground (control or CTR) for approximately 4 weeks. The wet weights of the quadriceps were significantly reduced in FLT mice. Next-generation sequencing and untargeted mass spectroscopic assays interrogated the gene-metabolite landscape of the quadriceps. A majority of top-ranked differentially suppressed genes in FLT encoded proteins from the myosin or troponin families, suggesting sarcomere alterations in space. Significantly enriched gene-metabolite networks were found linked to sarcomeric integrity, immune fitness, and oxidative stress response; all inhibited in space as per in silico prediction. A significant loss of mitochondrial DNA copy numbers in FLT mice underlined the energy deprivation associated with spaceflight-induced stress. This hypothesis was reinforced by the transcriptomic sequencing-metabolomics integrative analysis that showed inhibited networks related to protein, lipid, and carbohydrate metabolism, and adenosine triphosphate (ATP) synthesis and hydrolysis. Finally, we discovered important upstream regulators, which could be targeted for next-generation therapeutic intervention for chronic disuse of the musculoskeletal system.Entities:
Keywords: ANIMAL MODEL; METABOLISM; SKELETAL MUSCLE; SYSTEMS BIOLOGY; TISSUE SIGNALING
Mesh:
Substances:
Year: 2020 PMID: 32511780 PMCID: PMC7689867 DOI: 10.1002/jbmr.4102
Source DB: PubMed Journal: J Bone Miner Res ISSN: 0884-0431 Impact factor: 6.741
Fig 1(A) The timeline of Rodent Research 4 (RR4). The timeline depicts how the research was planned around the launch (L) of space shuttle SpaceX‐10. The types of assays reported in this article are listed at the end. Timeline is not to scale. (B) The wet mass of quadriceps, soleus, and EDL. The bar and whisker plot represents the median weight values with the 10 to 90 percentile. The hashed and white boxes represents FLT and CTR mice cohorts, respectively. The significance level of changes was calculated using Student’s t test. (C) The regulation of myosin protein in FLT versus CTR mice. The bar and whisker plot presents the median values with 10 to 90 percentile. The reduction of OD450 in FLT (white bar) in comparison to the CTR (hashed bar) was significant. (D) mtDNA CNV in FLT versus CTR mice. The y axis represents the ratio of CNs of mtDNA and nDNA. The bar and whisker plot presents the median values with 10 to 90 percentile. The significance level of changes was calculated using Student’s t test. BG = background; CN = copy number; CTR = control group on the ground; d = day; EDL = extensor digitorum longus; FLT = spaceflight; ISS = International Space Station; KSC = Kennedy Space Center; L = launch; m = months; mtDNA CNV = mitochondrial DNA copy number variation; nDNA = nuclear DNA; OD450 = optical density at 450 nm; w = weeks.
The 19 Quadriceps‐Specific Genes, Differentially Expressed Between the Spaceflight (FLT) and Ground Control (CTR) Mice, Meeting FDR Cutoff 0.1
| Gene symbol | Log2(fold change) |
| FDR | Entrez gene name | Location of encoded protein | Type of encoded protein |
|---|---|---|---|---|---|---|
| TNNT1 | −3.63 | 1.72E‐08 | 1.87E‐04 | Troponin T1, slow skeletal type | Cytoplasm | Other |
| MYH7 | −5.23 | 1.25E‐07 | 6.79E‐04 | Myosin heavy chain 7 | Cytoplasm | Enzyme |
| TNNC1 | −3.92 | 3.27E‐07 | 8.90E‐04 | Troponin C1, slow skeletal and cardiac type | Cytoplasm | Other |
| TNNI1 | −4.48 | 2.60E‐07 | 8.90E‐04 | Troponin I1, slow skeletal type | Cytoplasm | Other |
| MYL2 | −3.34 | 1.66E‐06 | 2.58E‐03 | Myosin light chain 2 | Cytoplasm | Other |
| MYLK4 | −1.46 | 1.48E‐06 | 2.58E‐03 | Myosin light chain kinase family member 4 | Cytoplasm | Kinase |
| PTPN3 | −1.77 | 1.63E‐06 | 2.58E‐03 | Protein tyrosine phosphatase, non‐receptor type 3 | Cytoplasm | Phosphatase |
| TPPP3 | 1.34 | 2.12E‐05 | 2.88E‐02 | Tubulin polymerization promoting protein family member 3 | Cytoplasm | Other |
| PER3 | −1.53 | 2.71E‐05 | 3.28E‐02 | Period circadian regulator 3 | Nucleus | Other |
| AVIL | 1.26 | 4.12E‐05 | 3.78E‐02 | Advillin | Plasma membrane | Other |
| GOLGA7B | 1.45 | 3.91E‐05 | 3.78E‐02 | Golgin A7 family member B | Other | Other |
| LRRC30 | 1.02 | 4.52E‐05 | 3.78E‐02 | Leucine rich repeat containing 30 | Other | Other |
| MYOZ2 | −2.24 | 4.40E‐05 | 3.78E‐02 | Myozenin 2 | Other | Other |
| 4832428D23Rik | 1.90 | 5.57E‐05 | 4.33E‐02 | NA | NA | NA |
| MYH2 | −1.47 | 7.76E‐05 | 5.62E‐02 | Myosin heavy chain 2 | Cytoplasm | Enzyme |
| TRIOBP | 0.87 | 1.12E‐04 | 7.61E‐02 | TRIO and F‐actin binding protein | Nucleus | Other |
| PER2 | −2.43 | 1.31E‐04 | 8.36E‐02 | Period circadian regulator 2 | Nucleus | Transcription regulator |
| PFN2 | −0.85 | 1.42E‐04 | 8.36E‐02 | Profilin 2 | Cytoplasm | Enzyme |
| DCAF4 | 0.88 | 1.68E‐04 | 9.60E‐02 | DDB1 and CUL4 associated factor 4 | Nucleus | Other |
We report the gene symbol, gene name, FDR, and corresponding p values. The location and type of the protein encoded by the gene is reported as well. There are four genes (ie, MYH7, MYL2, MYLK4, and MYH2) in this list that encode proteins related to myosin family. Similarly, there are three genes (ie, TNNT1, TNNC1, and TNN1) in this list that encode proteins related to the troponin family. These are the two most popular protein families in this list.
NA = not applicable.
Fig 2(A) Four noncanonical networks of interest, namely metabolic dysfunction, muscle health, inflammation, and mitochondrial dysregulation. The metabolic dysfunction includes dysfunctions in metabolism of carbohydrate, lipid, and protein, respectively. The Venn diagram at the center suggests the association among these four noncanonical functions, whereas the numbers inside the diagram represent overlapping DEGs and DEMs across the networks. The subnetworks under each noncanonical network are listed next to the color‐coded boxes representing their significance of enrichment calculated by hypergeometric t test. The color code of the range of log10(p values) is shown at the left bottom corner; two extreme points, namely the dark blue and light blue, represented by log10(p values) = 10 and 100, respectively. The numbers of molecules (DEGs + DECs) enriching each network are represented by different circles next to the columns of log10(p values). Circles bordered by broken line, solid line, double line, solid line + filled with hashed lines, and solid line + filled solid color represent the sample sizes <25, 50, 75, 100, and 125, respectively. The regulation status (activated versus inhibited) of the networks were computed by MAP algorithm. Only the activated networks were marked by upward red arrows; the remaining unmarked networks were inhibited as per MAP algorithm. (B) Bioenergetics networks inhibited in spaceflight. The oval, hexagonal, and rectangular shaped nodes represent gene, metabolite, and biofunction, respectively. Red color means upregulated and green means downregulated in spaceflight compared to controls. All of the biofunctions noted inside the clear rectangles were inhibited in spaceflight as predicted by the MAP algorithm supplied by IPA. The arrow‐headed and open‐ended edges represent the regulative and associative relationship between two connecting nodes. (C) A network cluster linked to cell survival and proliferation. The oval‐shaped and rectangular nodes are represented by gene and pathways, respectively. SOCS1 gene is a significant upstream regulator, which was upregulated in space as marked by red upward arrow. This regulator inhibits the JAK/STAT pathway as represented by the blunt headed edge between SOCS1 and JAK/STAT pathway. All the networks in this figure were inhibited in space as predicted by MAP. Their regulation status are shown by blue downward arrow. The arrow‐headed edges between the networks represent the activating relationships. (D) Hierarchical clustering of DEGs linked to the networks contributing to cell survival and proliferation. The genes enriching at least two of the five networks are clustered by Euclidean calculations. The color code of the gene regulation is in the left bottom. Deep red and blue colors represent upregulation and downregulation, respectively, whereas yellow represent no change. DEG = differentially expressed gene; DEMs = differentially expressed metabolites; IPA = Ingenuity Pathway Analysis; MAP = molecule activity predictor.
List of Upstream Regulators of Interest
| Upstream regulator | Name | Log2(fold change) |
|
| Molecules to regulate (gene/metabolite) |
|---|---|---|---|---|---|
| SOCS1 | Suppressor of cytokine signaling 1 | 2.02 | −2.14 | .02 | 9/1 |
| STAT5B | Signal transducer and activator of transcription 5B | 0.64 | 1.70 | 5.52E‐10 | 33/1 |
| SMAD3 | Mothers against decapentaplegic homolog 3 | 0.50 | 1.86 | .05 | 12/3 |
| HSF1 | Heat shock transcription factor 1 | 0.40 | −1.67 | 3.12E‐05 | 19/1 |
| MEHP | Mono‐(2‐ethyl hexyl) phthalate | 0.25 | −2.50 | 2.70E‐04 | 16/0 |
| PLAU | Plasminogen activator | −0.84 | −1.67 | .04 | 5/1 |
These upstream regulators are sorted based on their fold changes (FLT/CTR) transformed to log scale base 2.